On Tuesday, Outlook Therapeutics Inc (NASDAQ: OTLK) opened lower -3.42% from the last session, before settling in for the closing price of $1.90. Price fluctuations for OTLK have ranged from $0.87 to $9.25 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 58.87% at the time writing. With a float of $21.22 million, this company’s outstanding shares have now reached $32.91 million.
The firm has a total of 23 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Outlook Therapeutics Inc (OTLK) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Outlook Therapeutics Inc is 50.49%, while institutional ownership is 16.68%. The most recent insider transaction that took place on Sep 26 ’24, was worth 28,446. In this transaction Chief Financial Officer of this company bought 5,000 shares at a rate of $5.69, taking the stock ownership to the 5,946 shares.
Outlook Therapeutics Inc (OTLK) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 58.87% per share during the next fiscal year.
Outlook Therapeutics Inc (NASDAQ: OTLK) Trading Performance Indicators
Check out the current performance indicators for Outlook Therapeutics Inc (OTLK). In the past quarter, the stock posted a quick ratio of 0.57.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.43, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -0.85 in one year’s time.
Technical Analysis of Outlook Therapeutics Inc (OTLK)
Analysing the last 5-days average volume posted by the [Outlook Therapeutics Inc, OTLK], we can find that recorded value of 0.79 million was better than the volume posted last year of 0.62 million. As of the previous 9 days, the stock’s Stochastic %D was 76.73%. Additionally, its Average True Range was 0.14.
During the past 100 days, Outlook Therapeutics Inc’s (OTLK) raw stochastic average was set at 59.39%, which indicates a significant decrease from 73.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 58.23% in the past 14 days, which was lower than the 80.70% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5509, while its 200-day Moving Average is $3.1283.
